Design of a PROspective multi-national CLOTBUST collaboration on reperfusion therapies for stroke (CLOTBUST-PRO)

International Journal of Stroke

Volumn 3, Issue 1, 2008, Pages 66-72

  Saqqur, Maher ^a   Tsivgoulis, Georgios ^b,c   Molina, Carlos A ^d   Demchuk, Andrew M ^e   Garami, Zsolt ^f   Barreto, Andrew ^g   Spengos, Konstantinos ^c   Forteza, Alex ^h   Mikulik, Robert ⁱ   Sharma, Vijay K ^j   Brunser, Alex ^k   Martinez, Patricia ^l   Montaner, Joan ^d   Kohrmann, Martin ^m   Schellinger, Peter D ^m   Alexandrov, Andrei V ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e UNIVERSITY OF CALGARY   (Canada)

^f HOUSTON METHODIST HOSPITAL   (United States)

^g UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

ⁱ ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^j NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^k UNIVERSIDAD DEL DESARROLLO   (Chile)

^l HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^m UNIVERSITY HOSPITAL ERLANGEN   (Germany)

more..

Author keywords

Arterial occlusion; CLOTBUST; Outcome; Recanalization; Reperfusion; Stroke; tPA; Transcranial Doppler

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTERY OCCLUSION; ARTICLE; BOLUS INJECTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; CLINICAL TRIAL; CORRELATION ANALYSIS; DOPPLER ECHOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; RECANALIZATION; SAMPLE SIZE; SYMPTOM; TREATMENT DURATION; VALIDATION PROCESS;

FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; MULTICENTER STUDIES AS TOPIC; PROSPECTIVE STUDIES; REPERFUSION; RESEARCH DESIGN; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 38949156591     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2008.00167.x     Document Type: Article

References (27)

1. Hacke W, Donnan G, Fieschi C et al. ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363:768-74.
2. Heiss WD, Grond M, Thiel A et al. Tissue at risk of infarction rescued by early reperfusion: A positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke. J Cereb Blood Flow Metab 1998; 18:1298-307.
3. Memezawa H, Smith ML, Siesjo BK: Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats. Stroke 1992; 23:552-9.
4. Young AR, Touzani O, Derlon JM, Sette G, MacKenzie ET, Baron JC: Early reperfusion in the anesthetized baboon reduces brain damage following middle cerebral artery occlusion: A quantitative analysis of infarction volume. Stroke 1997; 28:632-7.
5. Molina CA, Montaner J, Abilleira S et al. Time course of tissue plasminogen activator-induced recanalization in acute cardioembolic stroke: A case-control study. Stroke 2001; 32:2821-7.
6. Rha JH, Saver JL: The impact of recanalization on ischemic stroke outcome: A meta-analysis. Stroke 2007; 38:967-73.
7. Christou I, Alexandrov AV, Burgin WS et al. Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke. Stroke 2000; 31:1812-6.
8. Alexandrov AV, Burgin SW, Demchuk AM, El-Mitwalli A, Grotta JC: Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: Sonographic classification and short-term improvement. Circulation 2001; 103:2897-902.
9. Ribo M, Alvarez-Sabin J, Montaner J et al. Temporal profile of recanalization after intravenous tissue plasminogen activator: Selecting patients for rescue reperfusion techniques. Stroke 2006; 37:1000-4.
10. Labiche LA, Al-Senani F, Wojner AW, Grotta JC, Malkoff M, Alexandrov AV: Is the benefit of early recanalization sustained at 3 months? A prospective cohort study. Stroke 2003; 34:695-8.
11. Alexandrov AV, Demchuk AM, Burgin WS, Robinson DJ, Grotta JC, CLOTBUST Investigators. Ultrasound-enhanced thrombolysis for acute ischemic stroke: Phase I. Findings of the CLOTBUST trial. J Neuroimaging 2004; 14:113-7.
12. Alexandrov AV, Molina CA, Grotta JC et al. CLOTBUST Investigators. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004; 351:2170-8.
13. Demchuk AM, Christou I, Wein TH et al. Accuracy and criteria for localizing arterial occlusion with transcranial Doppler. J Neuroimaging 2000; 10:1-12.
14. Molina CA, Alexandrov AV, Demchuk AM et al. CLOTBUST Investigators. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator. Stroke 2004; 35:151-6.
15. Demchuk AM, Burgin WS, Christou I et al. Thrombolysis in Brain Ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator. Stroke 2001; 32:89-93.
16. Saqqur M, Shuaib A, Alexandrov AV et al. Derivation of transcranial Doppler criteria for rescue intra-arterial thrombolysis: Multicenter experience from the Interventional Management of Stroke study. Stroke 2005; 36:865-8.
17. The National Institutes of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-7.
18. Ribo M, Garami Z, Uchino K, Song J, Molina CA, Alexandrov AV: Detection of reversed basilar flow with power-motion Doppler after acute occlusion predicts favorable outcome. Stroke 2004; 35:79-82.
19. Chernyshev OY, Garami Z, Calleja S et al. Yield and accuracy of urgent combined carotid/transcranial ultrasound testing in acute cerebral ischemia. Stroke 2005; 36:32-7.
20. Saqqur M, Shuaib A, Alexandrov AV et al. Derivation of transcranial Doppler criteria for rescue intra-arterial thrombolysis: Multicenter experience from the Interventional Management of Stroke study. Stroke 2005; 36:865-8.
21. Kim YS, Meyer JS, Garami Z, Molina CA, Pavlovic AM, Alexandrov AV: Flow diversion in transcranial Doppler ultrasound is associated with better improvement in patients with acute middle cerebral artery occlusion. Cerebrovasc Dis 2006; 21:74-8.
22. Saqqur M, Molina CA, Salam A et al. CLOTBUST Investigators. Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: A multicenter transcranial Doppler study. Stroke 2007; 38:69-74.
23. Tsivgoulis G, Saqqur M, Sharma VK et al. CLOTBUST Investigators. Association of pretreatment blood pressure with tissue plasminogen activator-induced arterial recanalization in acute ischemic stroke. Stroke 2007; 38:961-6.
24. Saqqur M, Uchino K, Demchuk AM et al. CLOTBUST Investigators. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007; 38:948-54.
25. Tsivgoulis G, Sharma VK, Lao AY, Malkoff MD, Alexandrov AV: Validation of transcranial Doppler with computed tomography angiography in acute cerebral ischemia. Stroke 2007; 38:1245-9.
26. Alexandrov AV, Grotta JC: Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 2002; 59:862-7.
27. Molina CA, Alvarez-Sabin J, Montaner J et al. Thrombolysis-related hemorrhagic infarction: A marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion. Stroke 2002; 33:1551-6.